Surgery Partners, INC Form 4 insider transactions

Blair E Hendrix, a Director of Surgery Partners, Inc., received 34,364 shares of common stock on June 18, 2026.

Director Blair E. Hendrix acquired 11,670 shares of Surgery Partners, Inc. common stock on June 5, 2026.

John A. Deane, a Director at Surgery Partners, Inc., has acquired 11,670 shares of common stock.

Laura L. Forese, a Director at Surgery Partners, Inc., acquired 11,670 shares of common stock on June 5, 2026, with vesting scheduled for June 5, 2027.

Surgery Partners, Inc. Director Clifford G. Adlerz acquired 11,670 shares of common stock on June 5, 2026, at a price of $13.71 per share.

Surgery Partners, Inc. reports a director's acquisition of 11,670 common shares.

Teresa DeLuca, a Director at Surgery Partners, Inc., acquired 11,670 shares of common stock on June 5, 2026, at a price of $13.71 per share.

Surgery Partners, Inc. Director Brent Turner acquired 11,670 shares of common stock on June 5, 2026, as part of a vesting plan.

Surgery Partners' Chief Human Resources Officer, Danielle Burkhalter, sold 3,469 shares of common stock to cover tax withholding obligations related to restricted stock vesting.

Surgery Partners' Chief Strategy Officer, Marissa Brittenham, sold 3,657 shares of common stock on March 13, 2026, to cover tax withholding obligations related to restricted stock vesting.

Surgery Partners, Inc. Chief Financial Officer David T. Doherty sold 8,867 shares of common stock to cover tax obligations related to restricted stock vesting.

Surgery Partners CEO Jason Eric Evans sold 20,400 shares of common stock to cover tax liabilities from restricted stock vesting.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, Inc., sold 5,798 shares of common stock to cover tax withholding obligations.

Surgery Partners' COO and National Group President, Justin Robert Oppenheimer, acquired 77,736 shares of common stock through restricted stock awards.

A Surgery Partners executive sold shares to cover tax withholding obligations related to restricted stock vesting.

A director at Surgery Partners, Inc. filed an amended Form 4 to correct an error regarding a reported share disposition and beneficial ownership.

Surgery Partners Director Teresa DeLuca reported a pre-planned sale of 20,018 shares of common stock for $22.74 per share, effective August 11, 2025.

A director at Surgery Partners, Inc. sold 20,018 shares of common stock for approximately $22.74 per share.

Surgery Partners CFO David T. Doherty sold 47,491 shares of common stock for $23.39 per share, a transaction executed under a pre-arranged 10b5-1 plan.

Patricia Anne Maryland, a Director at Surgery Partners, Inc., has acquired 6,861 shares of common stock at a price of $23.32 per share, which are set to vest in June 2026.

Teresa DeLuca, a Director at Surgery Partners, Inc. (SGRY), acquired 6,861 shares of common stock at $23.32 per share, increasing her direct beneficial ownership to 65,191 shares, with vesting scheduled for June 2026.

Laura L. Forese, a Director at Surgery Partners, Inc. (SGRY), has acquired 6,861 shares of common stock at a price of $23.32 per share, with the shares set to vest in June 2026.

Blair E. Hendrix, a Director and 10% Owner of Surgery Partners, Inc. (SGRY), has acquired 6,861 shares of common stock, increasing his direct beneficial ownership.

Surgery Partners, Inc. Director Clifford G. Adlerz reported the acquisition of 6,861 shares of common stock at a price of $23.32 per share, increasing his direct beneficial ownership to 57,434 shares, with vesting scheduled for June 2026.

Surgery Partners, Inc. Director Brent Turner has acquired 6,861 shares of common stock at $23.32 per share, increasing his beneficial ownership to 74,924 shares, with the newly acquired shares vesting in June 2026.

Surgery Partners, Inc. Director John A. Deane acquired 6,861 shares of common stock at $23.32 per share on June 10, 2025, under a Rule 10b5-1 trading plan.

Wayne DeVeydt, Executive Chairman of Surgery Partners, acquired 4,233 shares of common stock at $24.21 per share on March 21, 2025, bringing his total holdings to 105,203 shares.

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 612 shares of common stock on March 14, 2025, to cover tax obligations related to vesting restricted stock.

Danielle Burkhalter, Chief Human Resources Officer of Surgery Partners, Inc., sold 74 shares of common stock on March 14, 2025, to cover tax obligations related to vesting restricted stock.

William Trenton Webb, American Group President at Surgery Partners, sold 138 shares of common stock on March 14, 2025, to cover tax withholding obligations related to vesting restricted stock.